Q&A with Medical Director of ARC Clinical Research

Local Newspaper Four Point News Interviews Dr. Anurekha Chadha

Austin Regional Clinic’s new Clinical Research division broadens the organization’s research scope to include a wide range of conditions, explained Dr. Anurekha Chadha, Medical Director for the new division in an interview with local newspaper Four Point News.

She says the research opportunities are open to anyone in the community who wishes to participate and meets the eligibility requirements.

Below is an excerpt of the Four Point News interview where Dr. Chadha explains the value of medical research and how patients can enroll in the upcoming trials.

Four Point News (FPB): How will the new research division at Austin Regional Clinic impact the local residents who are patients?

Dr. Chadha: Patients will now have access to treatments that might not have been available before. We will work to bring study opportunities that can provide the most potential benefit to all those who take part. The expansion of ARC research, to be located at Wilson Parke, extends into common diseases like asthma, diabetes and high cholesterol. These research opportunities are available to everyone in the community who wants to take part — ARC patients living in the area as well as those who are interested but don’t see an ARC physician. Clinical research provides people the opportunity to actually help further the development new treatments for the common diseases we all know too well and to give back to the local, regional, national and global health system.

FPB: How do interested people volunteer to be a part of the medical research trials?

Dr. Chadha: This program is designed to involve those who have the potential to benefit from participation in the study. We’ll ask volunteers to participate if they meet the criteria for the study and people can reach out to us to learn if we have a study for them.

FPB: Is there a schedule of what will be researched and when?

Dr. Chadha: Right now we have three studies currently starting or ongoing that are looking for volunteers. Two studies are for people with the flu and one for people with arthritis pain in the knee or hip. We are in discussions with global researcher companies to bring their studies into our office. Some of these studies are for those with allergies, asthma, lung disease from smoking, diabetes, and others for common diseases. We’ll continue to network with national and global research companies to find new study opportunities that could benefit ARC’s patients and those in the community.

FPB: Why is it important to be part of medical research?

It is through medical research that advancements in science are made and the quality of medicine is improved.  Finding people to participate in clinical studies is the single biggest challenge facing the development of new treatments for diseases. Without volunteers taking part in the research of new treatments, these new treatments never become available.  

ARC Clinical Research is currently located at ARC Wilson Parke. Visit ARC Clinical Research for more details.

Tags: ARC Wilson Parke, ARC Clinical Research, Dr. Anurekha Chadha

More on this Topic

At ARC , Patients Can Also Participate in Critical Research

Austin Regional Clinic Wilson Parke  offers medical research to improve treatment for osteoarthritis, asthma and Type 2 diabetes – and is seeking neighboring residents interested in participating in new clinical trials. Local newspaper Community Impact detailed upcoming research “that can benefit the community as a whole.”

ARC Clinical Research now open at ARC Wilson Parke

ARC is excited to announce the expansion of our clinical research program. ARC Clinical Research, opened Tuesday, November 1, at ARC Wilson Parke, offering more patients access to cutting-edge research beyond the rheumatology clinical trials ARC currently conducts.

ARC Teams with Austin-based ENTvantage Diagnostics Dx for New Clinical Trial

ARC’s newest clinical trial tests a device that could help curb antibiotic overuse, "one of the most urgent threats to the public’s health,” according to the Centers for Disease Control (CDC).

ARC Clinical Research Featured in Community Impact

ARC Clinical Research, based at ARC Wilson Parke, is featured in an article in Community Impact’s Lake Travis/Westlake edition. The article explains ARC’s involvement in a global study for a new antiviral flu drug, Xofluza, that may be available as early as 2019.

ARC Clinical Research Studying Anti-Flu Drug in High-Risk Patients

ARC Clinical Research has been studying a new drug to fight the flu in high-risk patients, with the goal of being able to offer another flu treatment choice to patients in the future.